(1R,1'R,2S,2'S)-1,1'-(propane-1,3-diyl)bis(2-((2,6-diethyl-4-methylphenyl)carbamoyl)piperidine 1-oxide)

Catalog No. :
ACWCHD648
CAS No. :
1502814-74-5
Molecular Formula :
C37H56N4O4
Molecular Weight :
620.88

IUPAC Name:(1R,1'R,2S,2'S)-1,1'-(propane-1,3-diyl)bis(2-((2,6-diethyl-4-methylphenyl)carbamoyl)piperidine 1-oxide)

(1R,1'R,2S,2'S)-1,1'-(propane-1,3-diyl)bis(2-((2,6-diethyl-4-methylphenyl)carbamoyl)piperidine 1-oxide) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1R,1'R,2S,2'S)-1,1'-(propane-1,3-diyl)bis(2-((2,6-diethyl-4-methylphenyl)carbamoyl)piperidine 1-oxide)
IUPAC Name(1R,1'R,2S,2'S)-1,1'-(propane-1,3-diyl)bis(2-((2,6-diethyl-4-methylphenyl)carbamoyl)piperidine 1-oxide)
Molecular FormulaC37H56N4O4
Molecular Weight620.88
SMILESO=C([C@H]1[N@@+](CCC[N@@+]2([O-])[C@H](C(NC3=C(CC)C=C(C)C=C3CC)=O)CCCC2)([O-])CCCC1)NC4=C(CC)C=C(C)C=C4CC
InChI KeyNXOFOSZCXHWGOG-WXKUUGAPSA-N
SynonymNO-Feng-PDEtMPPi, 95%;2-Piperidinecarboxamide, 1,1'-(1,3-propanediyl)bis[N-(2,6-diethyl-4-methylphenyl)-, 1,1'-dioxide, (1R,1'R,2S,2'S)-;(1R,1'R,2S,2'S)-1,1'-(propane-1,3-diyl)bis(2-((2,6-diethyl-4-methylphenyl)carbamoyl)piperidine 1-oxide)
CAS No.1502814-74-5

Synthetic Route by SureRoute

1. ACWCHD648 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWCHD648 route product structure diagram
    ACWCHD6481502814-74-5
Inquiry

2. ACWCHD648 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWCHD648 route product structure diagram
    ACWCHD6481502814-74-5
Inquiry

Comments (0)